Selected research
Industry Research
Viral Vector Purification Media Industry Research Report 2026
Market perspective
The global Viral Vector Purification Media market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Viral Vector Purification Media is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Viral Vector Purification Media is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Viral Vector Purification Media is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Viral Vector Purification Media include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Viral Vector Purification Media market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Viral Vector Purification Media.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Viral Vector Purification Media Market by Company
Cytiva
Thermo Fisher Scientific
Repligen
Sartorius
Bio-Rad
Merck
Tosoh Bioscience
Astrea Bioseparations
JNC
Sepax Technologies
Sunresin
Bestchrom
NanoMicro
BioToolomics
Viral Vector Purification Media Segment by Type
AAV Affinity Media
Anion Exchange Media
Cation Exchange Media
Mixed-Mode Media
Core-Bead Flow-Through Media
Monolith and Membrane Adsorbers
Viral Vector Purification Media Segment by Application
AAV Gene Therapy Vector Production
Lentiviral Vector Production
Adenoviral Vector and Vaccine Production
Oncolytic Virus and VLP Production
Process Development and Scale-Up
QC and Analytical Sample Preparation
Viral Vector Purification Media Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Vector Purification Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Viral Vector Purification Media and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Vector Purification Media.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Viral Vector Purification Media manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Viral Vector Purification Media by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Viral Vector Purification Media in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- AAV Affinity Media
- Anion Exchange Media
- Cation Exchange Media
- Mixed-Mode Media
- Core-Bead Flow-Through Media
- Monolith and Membrane Adsorbers
Applications
- AAV Gene Therapy Vector Production
- Lentiviral Vector Production
- Adenoviral Vector and Vaccine Production
- Oncolytic Virus and VLP Production
- Process Development and Scale-Up
- QC and Analytical Sample Preparation
Companies covered
- Cytiva
- Thermo Fisher Scientific
- Repligen
- Sartorius
- Bio-Rad
- Merck
- Tosoh Bioscience
- Astrea Bioseparations
- JNC
- Sepax Technologies
- Sunresin
- Bestchrom
- NanoMicro
- BioToolomics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Viral Vector Purification Media by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 AAV Affinity Media
- 2.2.3 Anion Exchange Media
- 2.2.4 Cation Exchange Media
- 2.2.5 Mixed-Mode Media
- 2.2.6 Core-Bead Flow-Through Media
- 2.2.7 Monolith and Membrane Adsorbers
- 2.3 Viral Vector Purification Media by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 AAV Gene Therapy Vector Production
- 2.3.3 Lentiviral Vector Production
- 2.3.4 Adenoviral Vector and Vaccine Production
- 2.3.5 Oncolytic Virus and VLP Production
- 2.3.6 Process Development and Scale-Up
- 2.3.7 QC and Analytical Sample Preparation
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Viral Vector Purification Media Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Viral Vector Purification Media Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Viral Vector Purification Media Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Viral Vector Purification Media Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Viral Vector Purification Media Production by Manufacturers (2021-2026)
- 3.2 Global Viral Vector Purification Media Production Value by Manufacturers (2021-2026)
- 3.3 Global Viral Vector Purification Media Average Price by Manufacturers (2021-2026)
- 3.4 Global Viral Vector Purification Media Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Viral Vector Purification Media Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Viral Vector Purification Media Manufacturers, Product Type & Application
- 3.7 Global Viral Vector Purification Media Manufacturers Established Date
- 3.8 Global Viral Vector Purification Media Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cytiva
- 4.1.1 Cytiva Viral Vector Purification Media Company Information
- 4.1.2 Cytiva Viral Vector Purification Media Business Overview
- 4.1.3 Cytiva Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Cytiva Product Portfolio
- 4.1.5 Cytiva Recent Developments
- 4.2 Thermo Fisher Scientific
- 4.2.1 Thermo Fisher Scientific Viral Vector Purification Media Company Information
- 4.2.2 Thermo Fisher Scientific Viral Vector Purification Media Business Overview
- 4.2.3 Thermo Fisher Scientific Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Scientific Product Portfolio
- 4.2.5 Thermo Fisher Scientific Recent Developments
- 4.3 Repligen
- 4.3.1 Repligen Viral Vector Purification Media Company Information
- 4.3.2 Repligen Viral Vector Purification Media Business Overview
- 4.3.3 Repligen Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Repligen Product Portfolio
- 4.3.5 Repligen Recent Developments
- 4.4 Sartorius
- 4.4.1 Sartorius Viral Vector Purification Media Company Information
- 4.4.2 Sartorius Viral Vector Purification Media Business Overview
- 4.4.3 Sartorius Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Sartorius Product Portfolio
- 4.4.5 Sartorius Recent Developments
- 4.5 Bio-Rad
- 4.5.1 Bio-Rad Viral Vector Purification Media Company Information
- 4.5.2 Bio-Rad Viral Vector Purification Media Business Overview
- 4.5.3 Bio-Rad Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Bio-Rad Product Portfolio
- 4.5.5 Bio-Rad Recent Developments
- 4.6 Merck
- 4.6.1 Merck Viral Vector Purification Media Company Information
- 4.6.2 Merck Viral Vector Purification Media Business Overview
- 4.6.3 Merck Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Merck Product Portfolio
- 4.6.5 Merck Recent Developments
- 4.7 Tosoh Bioscience
- 4.7.1 Tosoh Bioscience Viral Vector Purification Media Company Information
- 4.7.2 Tosoh Bioscience Viral Vector Purification Media Business Overview
- 4.7.3 Tosoh Bioscience Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Tosoh Bioscience Product Portfolio
- 4.7.5 Tosoh Bioscience Recent Developments
- 4.8 Astrea Bioseparations
- 4.8.1 Astrea Bioseparations Viral Vector Purification Media Company Information
- 4.8.2 Astrea Bioseparations Viral Vector Purification Media Business Overview
- 4.8.3 Astrea Bioseparations Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Astrea Bioseparations Product Portfolio
- 4.8.5 Astrea Bioseparations Recent Developments
- 4.9 JNC
- 4.9.1 JNC Viral Vector Purification Media Company Information
- 4.9.2 JNC Viral Vector Purification Media Business Overview
- 4.9.3 JNC Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 JNC Product Portfolio
- 4.9.5 JNC Recent Developments
- 4.10 Sepax Technologies
- 4.10.1 Sepax Technologies Viral Vector Purification Media Company Information
- 4.10.2 Sepax Technologies Viral Vector Purification Media Business Overview
- 4.10.3 Sepax Technologies Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Sepax Technologies Product Portfolio
- 4.10.5 Sepax Technologies Recent Developments
- 4.11 Sunresin
- 4.11.1 Sunresin Viral Vector Purification Media Company Information
- 4.11.2 Sunresin Viral Vector Purification Media Business Overview
- 4.11.3 Sunresin Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Sunresin Product Portfolio
- 4.11.5 Sunresin Recent Developments
- 4.12 Bestchrom
- 4.12.1 Bestchrom Viral Vector Purification Media Company Information
- 4.12.2 Bestchrom Viral Vector Purification Media Business Overview
- 4.12.3 Bestchrom Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Bestchrom Product Portfolio
- 4.12.5 Bestchrom Recent Developments
- 4.13 NanoMicro
- 4.13.1 NanoMicro Viral Vector Purification Media Company Information
- 4.13.2 NanoMicro Viral Vector Purification Media Business Overview
- 4.13.3 NanoMicro Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 NanoMicro Product Portfolio
- 4.13.5 NanoMicro Recent Developments
- 4.14 BioToolomics
- 4.14.1 BioToolomics Viral Vector Purification Media Company Information
- 4.14.2 BioToolomics Viral Vector Purification Media Business Overview
- 4.14.3 BioToolomics Viral Vector Purification Media Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 BioToolomics Product Portfolio
- 4.14.5 BioToolomics Recent Developments
5 Global Viral Vector Purification Media Production by Region
- 5.1 Global Viral Vector Purification Media Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Viral Vector Purification Media Production by Region: 2021-2032
- 5.2.1 Global Viral Vector Purification Media Production by Region: 2021-2026
- 5.2.2 Global Viral Vector Purification Media Production Forecast by Region (2027-2032)
- 5.3 Global Viral Vector Purification Media Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Viral Vector Purification Media Production Value by Region: 2021-2032
- 5.4.1 Global Viral Vector Purification Media Production Value by Region: 2021-2026
- 5.4.2 Global Viral Vector Purification Media Production Value Forecast by Region (2027-2032)
- 5.5 Global Viral Vector Purification Media Market Price Analysis by Region (2021-2026)
- 5.6 Global Viral Vector Purification Media Production and Value, YOY Growth
- 5.6.1 North America Viral Vector Purification Media Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Viral Vector Purification Media Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Viral Vector Purification Media Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Viral Vector Purification Media Production Value Estimates and Forecasts (2021-2032)
6 Global Viral Vector Purification Media Consumption by Region
- 6.1 Global Viral Vector Purification Media Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Viral Vector Purification Media Consumption by Region (2021-2032)
- 6.2.1 Global Viral Vector Purification Media Consumption by Region: 2021-2026
- 6.2.2 Global Viral Vector Purification Media Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Viral Vector Purification Media Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Viral Vector Purification Media Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Viral Vector Purification Media Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Viral Vector Purification Media Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Viral Vector Purification Media Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Viral Vector Purification Media Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Viral Vector Purification Media Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Viral Vector Purification Media Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Viral Vector Purification Media Production by Type (2021-2032)
- 7.1.1 Global Viral Vector Purification Media Production by Type (2021-2032) & (t)
- 7.1.2 Global Viral Vector Purification Media Production Market Share by Type (2021-2032)
- 7.2 Global Viral Vector Purification Media Production Value by Type (2021-2032)
- 7.2.1 Global Viral Vector Purification Media Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Viral Vector Purification Media Production Value Market Share by Type (2021-2032)
- 7.3 Global Viral Vector Purification Media Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Viral Vector Purification Media Production by Application (2021-2032)
- 8.1.1 Global Viral Vector Purification Media Production by Application (2021-2032) & (t)
- 8.1.2 Global Viral Vector Purification Media Production Market Share by Application (2021-2032)
- 8.2 Global Viral Vector Purification Media Production Value by Application (2021-2032)
- 8.2.1 Global Viral Vector Purification Media Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Viral Vector Purification Media Production Value Market Share by Application (2021-2032)
- 8.3 Global Viral Vector Purification Media Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Viral Vector Purification Media Value Chain Analysis
- 9.1.1 Viral Vector Purification Media Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Viral Vector Purification Media Production Mode & Process
- 9.2 Viral Vector Purification Media Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Viral Vector Purification Media Distributors
- 9.2.3 Viral Vector Purification Media Customers
10 Global Viral Vector Purification Media Analyzing Market Dynamics
- 10.1 Viral Vector Purification Media Industry Trends
- 10.2 Viral Vector Purification Media Industry Drivers
- 10.3 Viral Vector Purification Media Industry Opportunities and Challenges
- 10.4 Viral Vector Purification Media Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst